Institute for International Research

For years, "Personalized Medicine" has been touted as the next wave in healthcare but progress to-date has been limited. Has the industry over-estimated the "value" of personalized medicine? Or has the industry been subconsciously slowing its progress for fear of the loss of profits from traditional blockbusters? Is it regulatory and reimbursement issues? Or is it technical /scientific challenges that has yet to be resolved?

If personalized medicine is an inevitable happening, how then, can one best approach and adopt it as part of your drug development to clinical strategy? From the pharma's perspective, do you acquire, grow organically or partner with a diagnostic company?

All these questions have been raised by you and your peers in the field, wanting to know what are the signs and what the next steps should be.

At IBC's 2009 Personalized Medicine conference, we will highlight some of these pertinent questions and engage the best speakers to share their experiences with you! Join us in December 10-11, 2009 in San Francisco for a 2-day highly charged and influential conference on Personalized Medicine - Revolutionizing Drug Development.

Call for Papers
The 2009 Personalized Medicine conference is designed to provide strategic and practical information to help the audience navigate the myriad developments in the personalized medicine and molecular diagnostics field, and to better understand where they stand vis-a-vis their competitors and how they should progress forward in this challenging field.

If you have a great story to tell, such as a biomarker or personalized medicine program gaining momentum, or a clinical update on a drug and diagnostic pairing, we like to hear from you!

View preliminary conference outlines and submission categories and submit your abstract proposal today.

Speaker submissions must be received by June 5th, 2009.